Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of atezolizumab plus chemotherapy as first-line treatment for patients with advanced nonsquamous non-small-cell lung cancer in China.
Shang, Fangjian; Zhang, Boyuan; Kang, Shuo.
Affiliation
  • Shang F; Department of General Surgery, the First Hospital of Hebei Medical University, Shijiazhuang, PR China.
  • Zhang B; Science and Technology Office, Hebei Medical University, Shijiazhuang, PR China.
  • Kang S; Medical Insurance Office, the Second Hospital of Hebei Medical University, Shijiazhuang, PR China.
Expert Rev Pharmacoecon Outcomes Res ; 23(3): 337-343, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36655382
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Health_economic_evaluation Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Health_economic_evaluation Limits: Humans Language: En Year: 2023 Type: Article